Cargando…

The Application of the Insulin to C-Peptide Molar Ratio (ICPR) in Primary Screening for Insulin Antibodies in Type 2 Diabetes Mellitus Patients: A Further Quantitative Study on the Relationship Between ICPR and Insulin Antibodies

PURPOSE: This study aimed to further quantify the relationship between insulin antibodies (IAs) and the 2-hour insulin to C-peptide molar ratio (2h-ICPR) using a multiple linear regression model in T2DM patients. METHODS: A total of 274 T2DM patients from April 2019 to December 2022 in Xiang’an Hosp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hua, Kai-Fang, Jing, Bo-Yang, Wu, Yan-Hui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134342/ https://www.ncbi.nlm.nih.gov/pubmed/37122678 http://dx.doi.org/10.2147/DMSO.S404222

Ejemplares similares

International Conference on Production Research (ICPR) Americas Region
por: Mejía, Gonzalo, et al.
Publicado: (2012)

Mitosis detection in breast cancer histological images An ICPR 2012 contest
por: Roux, Ludovic, et al.
Publicado: (2013)

A Framework for Usable and Effective Clinical Decision Support: Experience from the iCPR Randomized Clinical Trial
por: Kannry, Joseph, et al.
Publicado: (2015)

Characteristics of OGTT and Correlation Between the Insulin to C-Peptide Molar Ratio, HOMA-IR, and Insulin Antibodies in T2DM Patients
por: Hua, Kai-Fang, et al.
Publicado: (2022)

Rationale, design, and implementation protocol of an electronic health record integrated clinical prediction rule (iCPR) randomized trial in primary care
por: Mann, Devin M, et al.
Publicado: (2011)

Design and implementation of electronic health record integrated clinical prediction rules (iCPR): a randomized trial in diverse primary care settings
por: Feldstein, David A., et al.
Publicado: (2017)

A prospective observational study on impact of epinephrine administration route on acute myocardial infarction patients with cardiac arrest in the catheterization laboratory (iCPR study)
por: Aldujeli, Ali, et al.
Publicado: (2022)

Pattern recognition and information forensics: ICPR 2018 international workshops, CVAUI, IWCF, and MIPPSNA, Beijing, China, August 20-24, 2018, revised selected papers
por: Zhang, Zhaoxiang, et al.
Publicado: (2018)

Can the Molar Insulin: C-Peptide Ratio Be Used to Predict Hyperinsulinaemia?
por: Guildford, Lynda, et al.
Publicado: (2020)

Relationship between anti-insulin antibody production and severe insulin resistance in a diabetic cat
por: KOMIYA, Takumi, et al.
Publicado: (2021)

Exogenous insulin antibody syndrome (EIAS): a clinical syndrome associated with insulin antibodies induced by exogenous insulin in diabetic patients
por: Hu, Xiaolei, et al.
Publicado: (2017)

Insulinoma With Concomitant Insulin Antibodies
por: Iqbal, Anira, et al.
Publicado: (2021)

Influence of Insulin Receptor Single Nucleotide Polymorphisms on Glycaemic Control and Formation of Anti-Insulin Antibodies in Diabetes Mellitus
por: Massarenti, Laura, et al.
Publicado: (2022)

Serious diabetic ketoacidosis induced by insulin allergy and anti‐insulin antibody in an individual with type 2 diabetes mellitus
por: Takahashi, Kaio, et al.
Publicado: (2022)

Hyperinsulinemic hypoglycemia associated with insulin antibodies caused by exogenous insulin analog
por: Su, Chih-Ting, et al.
Publicado: (2016)

FRI631 Insulin Antibody Mediated Extremely Insulin Resistant In Pregnancy
por: Liu, Zhao, et al.
Publicado: (2023)

Development of monoclonal antibodies and quantitative ELISAs targeting insulin-degrading enzyme
por: DelleDonne, Anthony, et al.
Publicado: (2009)

The relationship between different C-peptide level and insulin dose of insulin pump
por: Wei, Yihan, et al.
Publicado: (2021)

Modern insulin and insulin therapy in diabetes mellitus.
por: Montgomery, D. A.
Publicado: (1978)

INSULIN ANTIBODY VARIATIONS IN RABBITS AND GUINEA PIGS AND MULTIPLE ANTIGENIC DETERMINANTS ON INSULIN
por: Arquilla, Edward R., et al.
Publicado: (1963)

Anti-Insulin Antibodies and Adverse Events with Biosimilar Insulin Lispro Compared with Humalog Insulin Lispro in People with Diabetes
por: Home, Philip, et al.
Publicado: (2018)

Clinical Pharmacology of Fast-Acting Insulin Aspart Versus Insulin Aspart Measured as Free or Total Insulin Aspart and the Relation to Anti-Insulin Aspart Antibody Levels in Subjects with Type 1 Diabetes Mellitus
por: Haahr, Hanne, et al.
Publicado: (2018)

Antibody-Mediated Extreme Insulin Resistance: The Importance of Pre-Treatment Screening
por: Mosaferi, Tina, et al.
Publicado: (2019)

Activation of the insulin receptor by an insulin mimetic peptide
por: Park, Junhee, et al.
Publicado: (2022)

The Effects of Anti-insulin Antibodies and Cross-reactivity with Human Recombinant Insulin Analogues in the E170 Insulin Immunometric Assay
por: Kim, Serim, et al.
Publicado: (2011)

SUN-186 Insulin Antibody Associated Severe Insulin Resistance Leading to Uncontrolled Hyperglycemia
por: Amir, Hajira, et al.
Publicado: (2019)

The effects of liraglutide on both hypereosinophilic insulin allergy and the characteristics of anti-insulin antibodies in type 2 diabetes mellitus: a case report
por: Hirai, Hiroyuki, et al.
Publicado: (2016)

Association of subclass distribution of insulin antibody with glucose control in insulin-treated type 2 diabetes mellitus: a retrospective observational study
por: Chen, Shuang, et al.
Publicado: (2023)

Diabetic Ketosis Caused by the Insulin Analog Aspart–Induced Anti-Insulin Antibody: Successful Treatment With the Newest Insulin Analog Glulisine
por: Yanai, Hidekatsu, et al.
Publicado: (2011)

Immunological Hypoglycemia Associated with Insulin Antibodies Induced by Exogenous Insulin in 11 Chinese Patients with Diabetes
por: Quan, Heng, et al.
Publicado: (2015)

Anti-Insulin Receptor Antibodies Improve Hyperglycemia in a Mouse Model of Human Insulin Receptoropathy
por: Brierley, Gemma V., et al.
Publicado: (2020)

Mycophenolate Mofetil and Plasmapheresis: A Treatment Option for Severe Insulin Resistance caused by Insulin Antibodies
por: Brooks, Danielle, et al.
Publicado: (2021)

Therapeutics of Diabetes Mellitus: Focus on Insulin Analogues and Insulin Pumps
por: Valla, Vasiliki
Publicado: (2010)

Multiplexed quantification of insulin and C-peptide by LC-MS/MS without the use of antibodies
por: Foulon, North, et al.
Publicado: (2022)

Activation of the human insulin receptor by non-insulin-related peptides
por: Kirk, Nicholas S., et al.
Publicado: (2022)

Use of cross-reactivity immunoassay to orient insulin replacement in diabetic patients with high levels of insulin antibodies
por: Cardoso Landaburu, Alejandro, et al.
Publicado: (2016)

Insulin degludec does not increase antibody formation versus insulin glargine: an evaluation of phase IIIa trials
por: Vora, J., et al.
Publicado: (2016)

Antibody-Mediated Inhibition of Insulin-Degrading Enzyme Improves Insulin Activity in a Diabetic Mouse Model
por: Fursht, Ofir, et al.
Publicado: (2022)

The neutrophil-lymphocyte ratio and its relationship with insulin resistance in obesity
por: KARAKAYA, Serdar, et al.
Publicado: (2019)

Relationship among Insulin Therapy, Insulin Resistance, and Severe Coronary Artery Disease in Type 2 Diabetes Mellitus
por: Song, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_a99gv4i1ksm2re92gt6t7iosvg